Innovations in the diagnosis and management of uveitis: promising research to address unmet patient needs

• Type of Material: Article
• Authors: Steven Yeh, Emory University; Ye Huang, University of Nebraska Medical Center; Joanne Thomas, Emory University
• Language: English
• Date: 2022-03-01
• Publisher: AME Publishing Company
• Publication Version: Final Published Version
• Copyright Statement: © 2009 - 2023 AME Publishing Company. All rights reserved.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.21037/aes-21-54
• Title of Journal or Parent Work: Annals of Eye Science
• Volume: 7
• Grant/Funding Information: This research was also supported an unrestricted departmental grant from Research to Prevent Blindness, Inc. to the Emory Eye Center, Emory University School of Medicine.; This project was supported by the National Eye Institute/National Institutes of Health core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine), National Eye Institute of the National Institutes of Health under award number R01 EY029594 (S Yeh). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.; Funding support was also provided by the Macula Society Retina Research Foundation, the Association for Research in Vision and Ophthalmology and the Stanley M. Truhlsen Family Foundation.
• Keywords: Uveitis; Eye
• Research Categories: Health Sciences, Opthamology

Abstract

Uveitis, or inflammation of the uveal tissues (iris, ciliary body and the choroid), and its contiguous structures, can lead to severe visual impairment and is among the leading causes of vision impairment worldwide (1). In clinical practice, specialists in uveitis and ocular immunology are called upon to manage a range of uveitis syndromes—infectious disease, noninfectious autoimmune conditions, and masquerade syndromes such as lymphoma. Moreover, ophthalmologists of all subspecialties (i.e., medical and surgical retina, corneal surgeons, orbital/oculoplastic surgeons, and comprehensive ophthalmologists) are called upon to manage uveitis syndromes, emphasizing clear importance to understanding common uveitis syndromes, diagnostic workups, and the state-of-the-art in uveitis and ocular inflammation care.